Active	Status	Sponsor type	Region	Phase	Filter
23 Active 14 Inactive 37 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

16 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Goldberg, David
ADapt, NCT05369403: A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab	Active, not recruiting	3	120	US	Lebrikizumab, LY3650150, DRM06	Eli Lilly and Company	Atopic Dermatitis	01/24	02/25
PLATyPuS, NCT02315898: Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis	Completed	2	40	US	Treatment-inhaled tPA, alteplase, Activase	University of Michigan, Genentech, Inc.	Plastic Bronchitis, Protein-Losing Enteropathies, Healthy	03/21	06/23
NCT04844840: A Study for Safety and Efficacy Evaluation of Various Doses of STP705 in Reducing Keloid Recurrence	Completed	2	29	US	STP705, STP705 Powder for Injection, Placebo	Sirnaomics	Keloid	05/23	05/23
NCT04844983: A Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCC	Completed	2	44	US	STP705, STP705 Powder for Injection, Placebo Saline	Sirnaomics	Squamous Cell Carcinoma in Situ	08/22	12/22
NCT06176768: A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis	Recruiting	2	75	US	LY3972406, Placebo	Eli Lilly and Company	Plaque Psoriasis	04/25	07/25
THINKER-NEXT, NCT04075916: A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients	Active, not recruiting	2	201	US	Epclusa	University of Pennsylvania, Gilead Sciences, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	End Stage Renal Disease	06/25	01/26
FALD, NCT03430583: Evaluation of Fontan-Associated Liver Disease	Active, not recruiting	N/A	100	Canada, US	MZ101	Mezzion Pharma Co. Ltd, National Heart, Lung, and Blood Institute (NHLBI)	Single Ventricle Heart Disease	06/21	08/21
NCT05358860: Safety and Efficacy of Sofwave Treatment for Acne Scars Appearance Improvement	Completed	N/A	60	US	Sofwave, SUPERB	Sofwave Medical LTD	Acne Scars - Mixed Atrophic and Hypertrophic	12/22	12/22
NCT05882721: Treatment for Improvement of Cellulite Appearance Using Form Applicator	Completed	N/A	60	US	Sofwave	Sofwave Medical LTD	Cellulite	11/23	11/23
NCT05323253: A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma	Recruiting	N/A	86	Canada, US, RoW	DaRT seeds, DaRT	Alpha Tau Medical LTD.	Recurrent Squamous Cell Carcinoma	12/24	12/25
Santangeli, Pasquale
RAAFT-3, NCT04037397: First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment	Completed	3	25	US	Anti Arrhythmics, Pulmonary Vein Isolation performed by Radio Frequency Catheter Ablation	University of Pennsylvania, Biosense Webster, Inc., Texas Cardiac Arrhythmia Research Foundation	Atrial Fibrillation	10/24	10/24
PLEA, NCT04216667: Posterior Wall And Left Atrial Appendage Empiric Electrical Isolation for Non-Paroxysmal Atrial Fibrillation	Terminated	N/A	124	Europe, US, RoW	Catheter ablation	Montefiore Medical Center, Biosense Webster, Inc.	Atrial Fibrillation	06/23	06/23
VTFM, NCT05708131: Outcomes of Functional Substrate Mapping of Ventricular Tachycardia	Recruiting	N/A	70	Europe, US		Mid and South Essex NHS Foundation Trust, Abbott	Ventricular Tachycardia	12/24	12/24
AIM-VT, NCT06138873: Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy	Recruiting	N/A	100	US	Ablation-index guided ventricular tachycardia ablation, Ventricular tachycardia ablation with no AI-guidance	Rush University Medical Center, University of Michigan, Medical University of South Carolina, The Cleveland Clinic, Biosense Webster, Inc.	Ventricular Tachycardia, Ischemic Cardiomyopathy	11/26	11/27
NCT06051994: Ablation-Index Guided Ventricular Tachycardia Ablations	Not yet recruiting	N/A	100	US	AI-guided VA ablation	Rush University Medical Center, Biosense Webster, Inc., University of Michigan, The Cleveland Clinic, Medical University of South Carolina	Ventricular Tachycardia, Ventricular Arrythmia, Cardiomyopathies	11/26	11/27
Patel, Mamta
NCT04740671 / 2020-005364-57: A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD	Completed	3	410	Europe, US, RoW	HLX04-O, ranibizumab	Shanghai Henlius Biotech	Age Related Macular Degeneration	12/24	12/24
Sharkoski, Tiffany
No trials found